Vident Investment Advisory, LLC Y M Abs Therapeutics, Inc. Transaction History

Vident Investment Advisory, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$15.51 - $29.31 $602,330 - $1.14 Million	-38,835 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$27.47 - $37.31 $76,201 - $103,497	-2,774 Reduced 6.67%	38,835 $1.11 Million
Q2 2021 Aug 13, 2021	BUY	$25.45 - $37.64 $258,826 - $382,798	10,170 Added 32.35%	41,609 $1.41 Million
Q4 2020 Feb 08, 2021	BUY	$37.86 - $54.26 $38,011 - $54,477	1,004 Added 3.3%	31,439 $1.56 Million
Q3 2020 Nov 12, 2020	SELL	$35.13 - $43.62 $71,313 - $88,548	-2,030 Reduced 6.25%	30,435 $1.17 Million
Q2 2020 Jul 17, 2020	SELL	$23.66 - $49.53 $288,107 - $603,126	-12,177 Reduced 27.28%	32,465 $1.4 Million
Q1 2020 May 12, 2020	SELL	$14.39 - $35.8 $45,587 - $113,414	-3,168 Reduced 6.63%	44,642 $1.17 Million
Q4 2019 Feb 11, 2020	SELL	$23.81 - $33.78 $399,079 - $566,186	-16,761 Reduced 25.96%	47,810 $1.49 Million
Q3 2019 Nov 13, 2019	SELL	$21.57 - $31.37 $39,796 - $57,877	-1,845 Reduced 2.78%	64,571 $1.68 Million
Q2 2019 Aug 12, 2019	SELL	$19.51 - $28.31 $106,329 - $154,289	-5,450 Reduced 7.58%	66,416 $1.52 Million
Q1 2019 May 08, 2019	SELL	$18.21 - $26.21 $42,884 - $61,724	-2,355 Reduced 3.17%	71,866 $1.88 Million
Q4 2018 Feb 14, 2019	BUY	$15.41 - $28.92 $1.14 Million - $2.15 Million	74,221 New	74,221 $1.51 Million

106

24.5M

40.3K

400

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $487M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Investment Advisory, LLC with notifications on news.